Fabino Life Sciences IPO – Review, Bid, Size, Allotment, Subscription, GMP & RHP
Last Updated Date: Nov 17, 2022Let’s have a detailed review of the company and analytics of the Fabino Life Sciences IPO release date, IPO offer price, subscription, Fabino Life Sciences Limited IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.
| Face Value | Rs 10 |
| Price Band | Rs 36 |
| Listing At | BSE, SME |
| Min. Order Quantity | 3000 Shares |
| Listing Date | Jan 13, 2022 |
| Offer for Sale | Rs Lakh |
| Fresh Issue | Rs 324 Lakh |
| IPO Size | Rs 324 Lakh |
| Tick Size | 1 |
Fabino Life Sciences IPO is listed at a [●] premium. Check out the live share price by clicking on the below link.
Fabino Life Sciences IPO – Summary
They are a growing pharmaceutical and other wellness-focused consumer Products Company operating from Delhi and Haryana. Their company emphasizes developing high-quality and affordable products for all sections of society by harnessing the skills of their competent manpower and other resources.
They aim at providing the best quality products at affordable rates for good health and well-being for all. Fabino Life sciences Ltd is engaged in manufacturing, marketing, trading, and Packing of pharmaceutical and other wellness-focused consumer products.
The Promoter of this company is Atul Kumar Jain. The lead manager to the issue is ARYAMAN FINANCIAL SERVICES LIMITED, and the Registrar to this issue is BIG SHARE SERVICES PRIVATE LIMITED.
Fabino Life Sciences IPO Date
The opening and the closing date of the Fabino Life Sciences IPO are Dec 31, 2021, and Jan 5, 2022, respectively.
Fabino Life Sciences IPO Subscription
| Day / Date | NII | RII | Total Subscription |
| 1st Day – 31st Dec | 0.79x | 0.78x | 0.79x |
| 2nd Day – 3rd Jan | 1.69x | 3.61x | 2.65x |
| 3rd Day – 4th Jan | 1.97x | 5.77x | 3.87x |
| 4th Day – 5th Jan | 3.49x | 10.36x | 6.93x |
| Shares Offered or Net Issue | 426,000 | 426,000 | 852,000 |
The shares subscribed by the public will be updated here.
Check Fabino Life Sciences IPO LIVE Subscription
- Fabino Life Sciences IPO LIVE Bid details on BSE
- Fabino Life Sciences IPO LIVE Bid details on NSE
For the Latest Bid details click on the above links.
Fabino Life Sciences IPO Allotment Status
Here, you can find the Allotment Status of this IPO.
Allotment of Equity Shares pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment Status is not yet disclosed.
Fabino Life Sciences Limited IPO Listing Date
Find the dates below on basis of allotment, refund, listing, and more:
| Basis of Allotment Finalization | Jan 10, 2022 |
| Refunds Initiation | Jan 11, 2022 |
| Credit of Shares to Demat Account | Jan 12, 2022 |
| Share Listing Date | Jan 13, 2022 |
Fabino Life Sciences IPO Price
The face value of each share is Rs.10, but the price band of the IPO is Rs.36
Fabino Life Sciences IPO Size
This Initial Public Issue of 9,00,000 Equity Shares of Rs.10 each for cash at a price of Rs.36 per equity share aggregating to Rs.324 Lakh.
Fabino Life Sciences IPO Share Offering
Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of [●] Equity Shares of Rs.10/ each.
Issue Size: 9,00,000 Equity Shares of Rs.10 each, aggregating to Rs.324 Lakh
Open Free Demat Account Now!
Fabino Life Sciences IPO – Live Performance
The listing date of this IPO is Jan 13, 2022. You can check the live performance of the IPO here, only after it is listed on exchanges.
| Live IPO Performance – Fabino Life Sciences Share Price |
Fabino Life Sciences IPO Grey Market Premium
The Fabino Life Sciences Limited IPO Grey Market Premium price is Rs X, the Kostak rate is Rs X and the Subject to Sauda is X.
Fabino Life Sciences IPO – Company Overview
Their core business is the marketing of Pharmaceutical formulation & products in the Domestic market through own distribution network and Salesforce under own brand name, Getting their Ayurvedic formulations manufactured through Loan Licensing facilities, Packing, Labeling, etc.
They export wellness and FMCG products like Coffee, Malt powder, Protein powder, Hair shampoo which is marketed by their company. Their Ayurvedic/Herbal business operations are supported by loan licensing facilities which are approved by relevant authorities. They typically enter into Loan License Agreement for periods ranging from one to five years.
They have been awarded a G.M.P Certification for following Good Manufacturing Practices of Ayurveda/Siddha/Unnani drugs under “Schedule T” of Drugs & Cosmetics Rules, 1945 in respect of various categories of Tablets, Capsules, Oils, Syrups, and Powder. For details on the government approvals, please refer to the chapter titled “Government and Other Key Approvals” on page no. 165 of this DP. They have a dedicated marketing team headed by their management looking after their business operations.
Their company is the brainchild of their promoter “Atul Kumar Jain” who has been the guiding force behind their growth. Backed by his 15 plus years of experience their promoter has been instrumental in shaping the value systems of their company.
Fabino Life Sciences IPO – Financial Statements
A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:
Financial Summary:
| Amount (in INR & Lakh) | ||||
| 30-Jun-21 | 31-Mar-21 | Mar-20 | 31-Mar-19 | |
| Total Assets | 281.42 | 225.19 | 358.85 | 855.38 |
| *Total Revenue | 112.90 | 305.92 | 751.69 | 276.16 |
| Total Expense | 110.95 | 301.67 | 741.78 | 275.83 |
| Profit After Tax | 1.42 | 3.02 | 6.89 | 0.01 |
Earnings per Equity Share (in Million)
| 30-Jun-21 | 31-Mar-21 | Mar-20 | 31-Mar-19 | |
| Basic & Diluted | 0.25 | 0.50 | 1.53 | 0.00 |
Further, their PAT for the period ended on March 31, 2021, March 31, 2020, and March 31, 2019, were Rs. 3.02 Lakh, Rs. 6.89 Lakh, and Rs. 0.01 Lakh respectively.
Fabino Life Sciences IPO – Promoters
The Promoter of this company is:
- Atul Kumar Jain
List of Related Parties (Key Managerial Personnel)
- Atul Kumar Jain, Chairperson & Managing Director
- Aditya Mahavir Jain, Whole Time Director
- Arihant Jain, Non-Executive Director
- Kuldeep Solanki, Non-Executive Independent Director
- Tesu Alakh, Non-Executive Independent Director
- Gagan Gupta, Non-Executive Independent Director
Fabino Life Sciences IPO – Promoters Holding
- Pre Issue Share Holding – 99.43%
- Pos Issue Share Holding – 56.82%
Fabino Life Sciences IPO Offer Details or Issue Details
| Particulars | No. Of Equity Shares |
| Equity Shares Offered | Up to 9,00,000 Equity Shares aggregating up to Rs.324 Lakh |
| of which: | |
| Issue Reserved for the Market Makers | Up to 48,000 Equity Shares aggregating up to Rs.[●] Lakh |
| Net Issue to the Public | Up to 4,26,000 Equity Shares aggregating up to Rs.2.00 Lakh |
| Of which: | |
| Retail Investors Portion | Not less than [●] Equity Shares |
| Other than Retail Individual Investors | Not more than [●] Equity Shares |
| Equity Shares outstanding prior to the Issue | 12,00,000 Equity Shares |
| Equity Shares outstanding after the Issue | 21,00,000 Equity Shares |
Fabino Life Sciences IPO Issue Object
Their Company proposes to utilize the Net Proceeds towards funding the following objects:
1. Part Repayment of Loans
2. Funding Working capital requirements
3. General Corporate Purpose
Fabino Life Sciences – Business Strategy
- Working Capital Augment
- Geographical Diversification
- Digital Marketing
Fabino IPO – Basis of Offer Price
The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.
Qualitative factors are:
- Experienced Promoter and management team with strong industry expertise and successful track record
- Existing well-established goodwill and client relationship
- Wide range of products to cater to the domestic and global market
- Scalable business model
The relevant quantitative factors are:
| Basic & Diluted EPS | RONW (%) | NAV (Rs.) | |
| 31-Mar-21 | 0.50 | 2.32 | 10.86 |
| 31-Mar-20 | 1.53 | 10.24 | – |
| Mar-19 | 0.00 | 0.02 | – |
Fabino IPO: Competitive Peers
| Face Value (Rs.) | P/E | EPS (Rs.) | Return on Net Worth (%) | Total Income (Rs. in Lakhs) | |
| Fabino Life Sciences Limited | 10 | [●] | 0.50 | 2.32 | 305.75 |
| Listed Peers | |||||
| Earum Pharmaceuticals Limited | 10 | 492.85 | 0.14 | 0.61 | 5001.57 |
| Vaishali Pharma Limited | 10 | 34.44 | 0.99 | 4.626 | 5377.39 |
| Chandra Bhagat Pharma Limited | 10 | 278 | 0.25 | 0.73 | 70.70 |
Fabino IPO Lead Managers
| Lead Managers |
| ARYAMAN FINANCIAL SERVICES LIMITED 60, Khatau Building, Ground Floor, Alkesh Dinesh Modi Marg Fort, Mumbai – 400 001 Tel No.:+91 22 6216 6999 Email: ipo@afsl.co.in Website: www.afsl.co.in Investor Grievance Email: feedback@afsl.co.in Contact Person: Vatsal Ganatra SEBI Registration No. INM000011344 |
Fabino Life Science IPO Registrar to offer
| Registrar to the Offer |
| BIGSHARE SERVICES PRIVATE LIMITED 1st Floor, Bharat Tin Works Building, Opp. Vasant Oasis Makwana Road, Marol, Andheri East, Mumbai – 400 059 Tel. No.: +91 22 6263 8200 Email: ipo@bigshareonline.com Website: www.bigshareonline.com Investor Grievance Email: investor@bigshareonline.com Contact Person: Babu Raphael SEBI Registration No.: INR000001385 |
Fabino Life IPO – Other Details
- Statutory Auditor – M/s. D G M S & Co., Chartered Accountants
- Legal Counsel to the Company – M/S. ABDUS SAMEE ABDUL QADIR MANIYAR
- Bankers to the Company – NA
Fabino Life IPO Review by Stock Brokers
| Top Stock Brokers Review | Company Reputation | Competitive Edge | Financial Statement | Popularity Index | Promoters Reputation |
| Angel Broking | 7.5/10 | 7.4/10 | 8.5/10 | 8.1/10 | 7.1/10 |
| Sharekhan | 7.2/10 | 7.1/10 | 8.6/10 | 8.1/10 | 7.2/10 |
| Kotak Securities | 7.3/10 | 7.5/10 | 8.4/10 | 8.1/10 | 7.3/10 |
| ICICI Direct | 7.3/10 | 7.3/10 | 8.7/10 | 8.1/10 | 7.1/10 |
| IIFL | 7.5/10 | 7.2/10 | 8.8/10 | 8.0/10 | 7.1/10 |
| Edelweiss | 7.5/10 | 7.4/10 | 8.4/10 | 8.3/10 | 7.2/10 |
| Zerodha | 7.4/10 | 7.1/10 | 8.5/10 | 8.1/10 | 7.0/10 |
| 5Paisa | 7.1/10 | 7.1/10 | 8.4/10 | 8.1/10 | 7.1/10 |
| Karvy | 7.4/10 | 7.3/10 | 8.2/10 | 8.1/10 | 7.1/10 |
| Motilal Oswal | 7.1/10 | 7.1/10 | 8.6/10 | 8.3/10 | 7.2/10 |
Subscribe to Fabino Life Sciences IPO
Fabino Life Sciences Limited IPO News
News 1 – IPO DRHP Download
News 2 – IPO RHP Prospectus Download
Fabino Life Sciences IPO Review FAQs
What is the Issue Size of Fabino Life IPO?
The Company is making an initial public offer of 9,00,000 equity shares. They vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and net issue.
What is the Price band of Fabino IPO?
The price band for this particular IPO ranges between Rs 36. As far as the face value of the share is of concern, it is Rs.10 per share.
What is the Fabino Life IPO Open Date?
The opening and closing dates for this IPO have been updated. The IPO is set to open on Dec 31, 2021, while the closing date is set at Jan 5, 2022.
What is the Fabino Life Sciences IPO Allotment Date?
They also have the news regarding the respective allotment dates of this IPO. Basis of Allotment finalization is on Jan 10, 2022, refund initiation is on Jan 11, 2022, credit of shares is on Jan 12, 2022, and share listing date is on Jan 13, 2022.
What is the Fabino Life Sciences IPO Listing Date?
Shares of this company shall be listed in the exchanges on Jan 13, 2022. The date, when the listing would be done, is stagnant on Jan 13, 2022.
Who is the Registrar of Fabino Life IPO?
One of the reputed registrars is managing the issue of this IPO, i.e. Bigshare Services Private Limited. Their website will help you regarding the further information you are on the lookout for.
Who is the Promoter of Fabino Life IPO?
Here are the promoters of this IPO – Atul Kumar Jain. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.
What is the GMP of Fabino Life IPO?
They have obtained the GMP of this IPO and it is NA. Further insights of Kostak rate and subject to sauda or SS are as well included in this report.
Is Fabino Life Sciences IPO good for Investment?
They have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.
What is the PAT of Fabino Life Sciences?
They have the information of company financials, and according to that, they have the figures from the last few years to provide. PAT for the financial year 2021 in Lakh is 3.02, 2020 is 6.89, 2019 is 0.01. PAT from June 2021 is 1.42.
Calculate your return on investment!
Asset Class
ROI (Rs.)
Profit (Rs.)
Profit (%)
IPO
Equity
Savings
Real Estate
Gold
Bonds
Fixed Deposit
Mutual Fund
Featured Topics